AI Article Synopsis
- Anterior Chamber bleeding can occur after receiving a Dexamethasone implant, similar to bleeding seen after vitrectomy procedures.
- A patient with macular edema due to central retinal vein occlusion experienced this type of bleeding post-injection, but there were no signs of vitreous hemorrhage.
- The bleeding was resolved with conservative treatment, highlighting that while complications can arise, they can often be managed effectively.
Article Abstract
Background: Anterior Chamber bleeding without vitreous hemorrhage had been described after the removal of 23G vitrectomy cannulas. We report the case of an anterior chamber bleeding after an intravitreal Dexamethasone implant.
Case Report: One patient with macular edema due to central retinal vein occlusion in a vitrectomized eye underwent an intravitreal Dexamethasone implant. After the injection the patient suffered from anterior chamber bleeding without signs of vitreous hemorrhage. The complication resolved with a conservative treatment.
Conclusion: Anterior Chamber bleeding is a possible complication of dexamethasone implant, that can be treated in a conservative way.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/11206721231178058 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!